ALLO

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday

12/16 02:09 pm

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

12/15 06:39 pm

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

11/27 12:00 pm

High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

07/23 09:26 am

Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO

06/01 10:45 am

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

03/05 02:00 pm

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

12/26 12:26 pm

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

10/22 01:00 pm

Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%

09/10 04:51 am

Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)

07/01 08:30 am

Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse

06/20 08:30 am

Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?

06/12 11:30 am

Analyst Ratings For Allogene Therapeutics

05/31 08:00 am

Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit

05/23 08:30 am

Breaking Down Allogene Therapeutics: 5 Analysts Share Their Views

05/15 03:02 pm

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

05/14 12:56 pm

Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates

05/13 05:10 pm

Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock

05/13 04:47 pm

Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update

05/13 04:01 pm

CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?

05/10 09:51 am

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates

05/09 05:25 pm

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

05/08 06:05 pm

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma

04/26 08:30 am

Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

04/25 10:02 am

Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?

04/24 10:01 am

To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation

04/18 02:29 pm

How Allogene (ALLO) Stock Stands Out in a Strong Industry

04/08 08:46 am

Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss

03/15 09:32 am

Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates

03/14 05:15 pm

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

03/14 04:05 pm

Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology

03/13 12:15 pm

Clene Inc. (CLNN) Reports Q4 Loss, Tops Revenue Estimates

03/13 09:30 am

Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease

03/12 08:30 am

Allogene Therapeutics (ALLO)'s Technical Outlook is Bright After Key Golden Cross

03/05 10:55 am

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

03/05 09:30 am

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia

02/16 09:30 am

CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday

02/12 11:22 am

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

01/16 05:05 pm

How Allogene (ALLO) Stock Stands Out in a Strong Industry

01/12 09:34 am

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

01/06 06:58 am

Cell Therapy Focused Allogene Therapeutics' Resource Prioritization A Bold Move, Says Analyst

01/05 03:32 pm

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

01/05 02:13 pm

Allogene (ALLO) Down 20% on Strategic Changes in Pipeline

01/05 01:52 pm

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

01/05 10:40 am

Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

01/05 07:19 am

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

01/04 05:15 pm

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

01/04 05:05 pm

Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference

01/03 05:05 pm

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

01/02 02:35 pm

The Zacks Analyst Blog Highlights Allogene Therapeutics, Arcutis Biotherapeutics and C4 Therapeutics

12/28 09:52 am